Boehringer Ingelheim
Ryan Gordon has extensive experience in oncology and medical affairs, currently serving as Senior Associate Director of Medical Affairs Strategy at Boehringer Ingelheim since September 2021, after previous roles as a Medical Science Liaison in oncology. Prior to this, significant academic contributions were made as a Research Assistant Professor at both OHSU and Northwestern University, focusing on oncology drug discovery and molecular pharmacology. Earlier research at the Fred Hutchinson Cancer Research Center and North Carolina State University involved independent management of prostate cancer and genetics research projects, respectively. Ryan Gordon holds a Ph.D. in Human Nutrition from the University of North Carolina at Chapel Hill and a Bachelor of Science in Animal Sciences from California Polytechnic State University-San Luis Obispo.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.